ElectroCore, Inc. was founded in 2005 with a mission to utilize neuromodulation in innovative ways to assist patients in breaking free from unsatisfactory treatments. Specializing in Health Care, Health and Wellness, and Medical Devices, the United States-based company focuses on developing safe and clinically backed treatments using the power of nVNS, innovation, and technology. Their commitment lies in improving patient treatment options and lives globally. The latest investment of $9.30M in post-IPO equity was secured on 03 June 2024.
General Information
Get notified when electroCore, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track electroCore, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Health Care
About electroCore, Inc.
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $9.30M | - | 03 Jun 2024 | |
| Post-IPO Equity | $1.55M | - | 27 May 2020 | |
| Post-IPO Equity | $463.68K | - | 18 May 2020 | |
| Post-IPO Equity | $1.75M | - | 29 Apr 2020 | |
| Series B | $34.00M | 4 | Merck Global Health Innovation Fund, Knoll Capital Management +1 | 29 Nov 2017 |
electroCore, Inc. Alternatives & Competitors
A pioneer in the development of bimodal neuromodulation treatments
Brain interfaces for better health: Scientifically grounded. Technically ambitious.
'Enhancing Lives with Bioelectronics'
FAQ About electroCore, Inc.
Don't just browse. Track.
Signal Tracker monitors electroCore, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.